Dr. Hajra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Emerson Place, Apt 10M
Boston, MA 02114Phone+1 617-732-5500
Summary
- Dr. Adrija Hajra is an attending physician at Brigham and Women's Hospital, Boston, MA. Dr. Hajra has received a medical degree from RG Kar Medical College Kolkata, India, and has been practicing for 10 years. Dr. Hajra specializes in /Internal Medicine/Hospital Medicine. Dr. Hajra has more than 90 publications and over 950 citings.
Education & Training
- Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2019 - 2022
- Institute of Post Graduate Medical Education and Research, SSKM Hospital, KolkataMD, 2014 - 2017
- RG Kar Medical College CalcuttaClass of 2013, MBBS
- Royal College of Physician, London, UKMRCP
Certifications & Licensure
- MA State Medical License 2023 - 2025
- NY State Medical License 2022 - 2024
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 5 citationsPresent Knowledge on Direct Oral Anticoagulant and Novel Oral Anti Coagulants and Their Specific Antidotes: A Comprehensive Review Article.Suman Biswas, Yasemin Bahar, Abdul Rasheed Bahar, Israel Safiriyu, Sheetal Vasundhara Mathai
Current Problems in Cardiology. 2023-02-01 - 8 citationsImpact of Atrial Fibrillation on Acute Coronary Syndrome-Analysis of In-Hospital Outcomes and 30-Day Readmissions.Bharat Narasimhan, Neelkumar Patel, Sandipan Chakraborty, Dhrubajyoti Bandyopadhyay, Jayakumar Sreenivasan
Current Problems in Cardiology. 2021-04-01 - 20 citationsGout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes.Subuhi Kaul, Manasvi Gupta, Dhrubajyoti Bandyopadhyay, Adrija Hajra, Prakash Deedwania
American Journal of Cardiovascular Drugs. 2021-09-01
Press Mentions
- Does the Presence of Cardiovascular Risk Factors or Established Cardiovascular Disease Affect the Survival of Patients with COVID-19?September 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: